Organogenesis Holdings's market cap is currently ―. The company's EPS TTM is $0.043; its P/E ratio is 65.55; Organogenesis Holdings is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is

lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 99.65M	$ 108.53M	$ 117.32M	$ 107.64M	$ 114.52M
Gross Profit	$ 71.88M	$ 82.74M	$ 117.32M	$ 81.03M	$ 87.41M
EBIT	$ -1.29M	$ 8.08M	$ 9.77M	$ -3.98M	$ 7.72M
EBITDA	$ 5.04M	-	$ 15.18M	$ 1.89M	$ 12.28M
Net Income Common Stockholders	$ -569.00K	$ 3.17M	$ 5.32M	$ -2.97M	$ 6.49M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 103.84M	$ 98.23M	$ 89.51M	$ 89.42M	$ 103.29M
Total Assets	$ 460.02M	$ 462.65M	$ 450.31M	$ 446.11M	$ 449.36M
Total Debt	$ 98.98M	$ 122.81M	$ 122.67M	$ 122.35M	$ 123.79M
Net Debt	$ -4.86M	$ 24.59M	$ 33.16M	$ 32.94M	$ 20.50M
Total Liabilities	$ 181.36M	$ 185.78M	$ 179.03M	$ 182.41M	$ 183.69M
Stockholders Equity	$ 278.66M	$ 276.87M	$ 271.28M	$ 263.70M	$ 265.67M
Cash Flow	-
Free Cash Flow	$ 7.29M	-	$ 1.15M	$ -12.64M	$ -2.86M
Operating Cash Flow	$ 10.61M	$ 16.73M	$ 8.65M	$ -5.08M	$ 7.80M
Investing Cash Flow	$ -3.32M	$ -5.98M	$ -7.50M	$ -7.56M	$ -10.66M
Financing Cash Flow	$ -1.78M	$ -1.44M	$ -1.05M	$ -1.24M	$ -1.88M

Currency in USD

Organogenesis Holdings Earnings and Revenue History

Income Statement >

Organogenesis Holdings Debt to Assets

Balance Sheet >

Organogenesis Holdings Cash Flow

Cash Flow >

Organogenesis Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing